Search research articles
Contact Us
Filters
Showing results (601-610 of 724) with videos related to
Page
of 73
Sort By:
American Journal of Otolaryngology
|
June 25, 2021
A closer look at 30 day hospital readmissions after head and neck cancer surgery
R Puccia, A Ramamurthi, S E Grond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 21, 2013
Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer
A J Armstrong, M Häggman, W M Stadler, et al.
Cancer
|
February 2, 2019
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2
James K Godfrey, Chadi Nabhan, Theodore Karrison, et al.
European Journal of Haematology
|
June 20, 2002
Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells
M Aivado, A Rong, M Stadler, et al.
BJU International
|
November 22, 2014
Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial
Friedrich-Carl von Rundstedt, Douglas A Mata, Susan Groshen, et al.
Leukemia
|
February 1, 2012
Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT
A Spyridonidis, M Labopin, C Schmid, et al.
Cancer
|
August 6, 2013
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance)
Rahul Aggarwal, Susan Halabi, William Kevin Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2012
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401
William Kevin Kelly, Susan Halabi, Michael Carducci, et al.
Investigational New Drugs
|
May 10, 2011
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium
Manish R Sharma, Kristen Wroblewski, Blase N Polite, et al.
Cancer
|
February 26, 2004
Gene expression profiling of renal medullary carcinoma: potential clinical relevance
Ximing J Yang, Jun Sugimura, Maria S Tretiakova, et al.
Page
of 73
Search research articles
Search
Showing results (601-610 of 724) with videos related to
Sort By:
Page
of 73
American Journal of Otolaryngology
|
June 25, 2021
A closer look at 30 day hospital readmissions after head and neck cancer surgery
R Puccia, A Ramamurthi, S E Grond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 21, 2013
Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer
A J Armstrong, M Häggman, W M Stadler, et al.
Cancer
|
February 2, 2019
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2
James K Godfrey, Chadi Nabhan, Theodore Karrison, et al.
European Journal of Haematology
|
June 20, 2002
Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells
M Aivado, A Rong, M Stadler, et al.
BJU International
|
November 22, 2014
Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial
Friedrich-Carl von Rundstedt, Douglas A Mata, Susan Groshen, et al.
Leukemia
|
February 1, 2012
Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT
A Spyridonidis, M Labopin, C Schmid, et al.
Cancer
|
August 6, 2013
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance)
Rahul Aggarwal, Susan Halabi, William Kevin Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2012
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401
William Kevin Kelly, Susan Halabi, Michael Carducci, et al.
Investigational New Drugs
|
May 10, 2011
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium
Manish R Sharma, Kristen Wroblewski, Blase N Polite, et al.
Cancer
|
February 26, 2004
Gene expression profiling of renal medullary carcinoma: potential clinical relevance
Ximing J Yang, Jun Sugimura, Maria S Tretiakova, et al.
Page
of 73